Michael Miller
RX Communications (Investor Relations)
Replay available
ReShape Lifesciences, Inc. (RSLS) Q4 2023 Earnings Call
ReShape Lifesciences, Inc. (NASDAQ: RSLS) Q4 2023 earnings conference call, held 2024-04-01. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Christine Renfielding
Professor of Surgery, NYU Grossman School of Medicine; Director, NYU Langone Weight Management Program; Chief, Division of Bariatric Surgery
Tom Stankovich
Chief Financial Officer
Paul Hickey
President and Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vyome Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.730 Good afternoon, and thank you for joining the Reshape Life Sciences Year-End 2023 00:00:05.730 -- 00:00:12.431 Conference Call. I would like to turn the call over to Michael Miller from RX Communications. 00:00:13.792 -- 00:00:18.932 Good afternoon, and thank you for joining the Year-End 2023 Reshape Life Sciences Earnings 00:00:18.932 -- 00:00:23.953 Call. I'm pleased to be joined today by Paul Hickey, President and Chief Executive 00:00:23.953 -- 00:00:27.950 Officer, and Tom Stankovich, Chief Financial Officer. 00:00:27.950 -- 00:00:32.513 Paul will provide an overview and update on the company's activities, which will include 00:00:32.513 -- 00:00:36.976 a discussion with Dr. Christine Renfielding, a member of Reshape Scientific Advisory 00:00:36.976 -- 00:00:41.138 Board. Then Tom will review the financial results for the period. 00:00:41.138 -- 00:00:45.401 We'll then turn the call back over to Paul for some closing remarks, after which we will 00:00:45.401 -- 00:00:49.083 open the call to a question and answer session. 00:00:49.083 -- 00:00:54.087 As a reminder, this conference call, as well as Reshape Life Sciences SEC filings 00:00:54.087 -- 00:00:59.568 and website, including the information, Investor information section of the website contains 00:00:59.568 -- 00:01:03.810 forward-looking statements within the meaning of the Private Securities Litigation Reform 00:01:03.810 -- 00:01:05.690 Act of 1995. 00:01:05.690 -- 00:01:10.472 Actual results could differ materially from those discussed due to known and unknown 00:01:10.472 -- 00:01:15.534 risks, uncertainties, and other factors. These and additional risks and uncertainties 00:01:15.534 -- 00:01:20.056 are described more fully in the company's filings with the Securiti...